Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

288
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
288
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

453
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
453
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

334
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
334
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

1.7K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.7K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

354
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
354
  1. 首页
  2. 抗精神病药物和失调的葡萄糖平衡:系统性审查和元分析
  1. 首页
  2. 抗精神病药物和失调的葡萄糖平衡:系统性审查和元分析

相关实验视频

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
07:30

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

9.4K

抗精神病药物和失调的葡萄糖平衡:系统性审查和元分析

Emily C C Smith1,2, Sri Mahavir Agarwal1,2,3,4, Kristoffer J Panganiban1,2

  • 1Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.

JAMA psychiatry
|August 27, 2025

在PubMed 上查看摘要

概括
此摘要是机器生成的。

抗精神病药物的使用显着破坏葡萄糖的控制,增加快食葡萄糖,胰岛素和HbA1c水平,独立于体重增加. 对服用这些药物的患者来说,对代谢健康的监测至关重要.

更多相关视频

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

1.7K
Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

10.4K

相关实验视频

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
07:30

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

9.4K
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

1.7K
Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

10.4K

科学领域:

  • 药理学和内分泌学
  • 代谢健康
  • 精神病医学

背景情况:

  • 抗精神病药物 (AP) 诱导的葡萄糖平衡变化通常与体重增加有关.
  • 然而,血糖控制失调可能独立于体重增加.
  • 这项研究调查了AP使用与葡萄糖代谢之间的直接关联.

研究的目的:

  • 检查抗精神病药物使用与葡萄糖平衡之间的关联.
  • 在这种关系中考虑体重增加倾向,药物类型和治疗持续时间.
  • 提供AP治疗患者代谢监测的证据.

主要方法:

  • 对随机临床试验 (RCT) 进行了系统审查和元分析.
  • 搜索包括从创立到2025年2月的主要数据库.
  • 包括163个RCT,其中127个用于元分析,比较患者和健康志愿者的AP与安慰剂.

主要成果:

  • 与安慰剂相比,AP使用显著增加了禁食葡萄糖,禁食胰岛素,糖化血红蛋白 (HbA1c) 和高血糖.
  • 这些效应在严重精神疾病患者和健康志愿者中观察到.
  • 亚组分析和元回归表明,AP诱导的葡萄糖失调与AP类型,剂量,研究长度,诊断,年龄或先前暴露无关.

结论:

  • 抗精神病药物暴露显著扰乱葡萄糖平衡,无论体重增加,持续时间或剂量.
  • 在服用抗精神病药物的患者中,需要提高意识和代谢监测.
  • 早期发现和治疗失糖症对于患者的护理至关重要.